Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia
about
HFE Gene Mutations and Iron Status in 100 Healthy Polish Children.Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis.Cardiovascular disease in adult survivors of childhood cancer.Individual prediction of heart failure among childhood cancer survivors.Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.Clinical Guidelines for the Care of Childhood Cancer Survivors.Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation SurvivorsCELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.The impact of H63D HFE gene carriage on hemoglobin and iron status in children.Treatment-related cardiotoxicity in survivors of childhood cancer.The role of iron in anthracycline cardiotoxicity.Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.Cardiovascular prevention in the cancer survivor.Anthracycline-Induced Cardiomyopathy in Adults.A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.Heart failure and chemotherapeutic agents.Cardiac complications in childhood cancer survivors treated with anthracyclines.Preventing pediatric cardiomyopathy: a 2015 outlook.Prevention of cardiotoxicity among survivors of childhood cancer.Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.Late Cardiotoxicity: Issues for Childhood Cancer Survivors.Pharmacogenetics of anthracyclines.Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.Cardiomyopathic Toxicity From Chemotherapy: Is There an Opportunity for Preemptive Intervention?Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway.Chemotherapy-induced cardiotoxicity in children.Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Platform for Testing For Drug Cardiotoxicity.State of the art review: Chemotherapy-induced cardiotoxicity in children.Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research.Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma.Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.Genetic Infiltrative Cardiomyopathies.
P2860
Q30491412-A09FE0F1-DADB-4FD4-949E-A5FC1BF81545Q33671281-B9003342-2F77-4033-BE34-734EFD89EAD2Q34042984-2A791A4C-1C6A-4054-A02F-D4CB2298AA26Q35040680-725F4F0D-1E0B-4FE1-A6C1-08267F6DEB24Q35296244-2D7548A0-AE3F-450F-B0F6-BD7675A54D29Q35562745-77285456-04AC-4B94-B021-648CB9CBC847Q36004460-597F3939-59C3-400A-98F6-736B0A42D670Q36649653-D88DEEDC-677E-4F5C-AFF3-A114BE7797DFQ37055826-EB5C2CF6-6137-4B65-AF0E-3A2C69817295Q37159230-B9DA7AB4-FB99-4697-920C-6E2405A75C15Q37350809-8771A3EB-5954-41F4-9C9A-1910DA9F658AQ37389711-30779B1B-3B90-4786-B234-4A5E21615CF1Q38156036-3640EE37-46E1-49E4-B5B2-BED563BB2B48Q38195038-CBFBCD79-774B-44DB-917A-2826B3B46B86Q38205702-F11046ED-3C16-4ADD-ADF2-A0CFF4B33E72Q38338228-1CAC346F-D44F-4C49-8474-8AD6EB583A82Q38542462-A6DAB9C3-2517-41B6-AB5A-B14042F8309AQ38545052-FABFD82F-47BC-4D8D-82DD-E00E8A16C29AQ38559133-ECCEB6D4-EC92-46B3-859A-F073096EBFABQ38588167-4CD0334E-70A0-4378-8EA9-FFD88EEA9786Q38662111-06AB9B89-D0E8-4DF1-AA08-1D5E2DD8779BQ38824644-69C5B672-46D8-4990-BC2C-C0A905D35CC9Q38838517-0E111CC0-4729-4425-BF3C-23D4544884A7Q38845457-B0430317-0FD2-462A-BC2D-272C04B48738Q38856218-ECA9A96A-8AFF-4770-9F4D-F0F625FB76D9Q38895172-D519B358-909A-4A53-AA0F-FC0C19086BFCQ38904284-B7DFA423-EA69-446E-BCE6-93489DCB598EQ39161075-9F8069F9-71C3-4B2F-AFC6-9B52A34F9811Q39415815-0C7AC7E3-AFDD-4B39-A259-054DA149C3C8Q40039502-29F39BC2-36CA-41A5-91E9-7542A5A90BD3Q42130469-5EF46752-E1D0-45F8-A0D3-DC74DC7CB6ABQ46801702-8A409F49-DD57-4A7D-B053-7D06FA78E80DQ48143732-F4479646-3010-4504-9D2B-C897063D80AFQ48331843-1D9FDD59-1B88-48C2-A879-D3A3520A8161Q49617830-1B42C3D3-A402-4F3A-8C42-156334216F62Q53564509-3BE435BA-DEF0-4934-A4F1-4703D1C46423Q53672562-26A815B0-F9E9-439E-AFD8-EC547C3CC512Q54986978-7F9D4E07-2AEA-4702-97B3-4FBD171BFC52
P2860
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of hemochromatosis gene ...... f childhood high-risk leukemia
@en
Impact of hemochromatosis gene ...... childhood high-risk leukemia.
@nl
type
label
Impact of hemochromatosis gene ...... f childhood high-risk leukemia
@en
Impact of hemochromatosis gene ...... childhood high-risk leukemia.
@nl
prefLabel
Impact of hemochromatosis gene ...... f childhood high-risk leukemia
@en
Impact of hemochromatosis gene ...... childhood high-risk leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Impact of hemochromatosis gene ...... f childhood high-risk leukemia
@en
P2093
Barbara L Asselin
Bruno Michon
Caroline Laverdiere
Donna S Neuberg
Eric Larsen
Jacqueline M Henkel
Jeffery L Kutok
Kara M Kelly
Kristen E Stevenson
Lewis B Silverman
P2860
P304
P356
10.1002/CNCR.28256
P407
P577
2013-07-16T00:00:00Z